Id1 and Id3 co-expression correlates with clinical outcome in stage III-N2 non-small cell lung cancer patients treated with definitive chemoradiotherapy.

Id1 and Id3 co-expression correlates with clinical outcome in stage III-N2 non-small cell lung cancer patients treated with definitive chemoradiotherapy.

Item
http://www.wikidata.org/entity/Q36597275
Id2, Id3 and Id4 overcome a Smad7-mediated block in tumorigenesis, generating TGF-β-independent melanoma.Increased expression of Id1 and Id3 promotes tumorigenicity by enhancing angiogenesis and suppressing apoptosis in small cell lung cancerGCIP functions as a tumor suppressor in non-small cell lung cancer by suppressing Id1-mediated tumor promotionHigh Id1 expression, a generally negative prognostic factor, paradoxically predicts a favorable prognosis for adjuvant paclitaxel plus cisplatin therapy in surgically treated lung cancer patients.Effects of an 11-nm DMSA-coated iron nanoparticle on the gene expression profile of two human cell lines, THP-1 and HepG2ID proteins regulate diverse aspects of cancer progression and provide novel therapeutic opportunities.Inhibitor of Differentiation/DNA Binding 1 (ID1) Inhibits Etoposide-induced Apoptosis in a c-Jun/c-Fos-dependent Manner.Overcoming chemoresistance in prostate cancer with Chinese medicine Tripterygium wilfordii via multiple mechanisms.Molecular markers to predict clinical outcome and radiation induced toxicity in lung cancerRole of ID Proteins in BMP4 Inhibition of Profibrotic Effects of TGF-β2 in Human TM Cells.Effects of upregulation of Id3 in human lung adenocarcinoma cells on proliferation, apoptosis, mobility and tumorigenicity.Contribution of Inhibitor of DNA Binding/Differentiation-3 and Endocrine Disrupting Chemicals to Pathophysiological Aspects of Chronic Disease.ATF3 suppresses ESCC via downregulation of ID1.ID1 promotes hepatocellular carcinoma proliferation and confers chemoresistance to oxaliplatin by activating pentose phosphate pathway.New role of ID3 in melanoma adaptive drug-resistance.
P2860

Id1 and Id3 co-expression correlates with clinical outcome in stage III-N2 non-small cell lung cancer patients treated with definitive chemoradiotherapy.

Item
http://www.wikidata.org/entity/Q36597275
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Id1 and Id3 co-expression corr ...... definitive chemoradiotherapy.
@ast
Id1 and Id3 co-expression corr ...... definitive chemoradiotherapy.
@en
type
label
Id1 and Id3 co-expression corr ...... definitive chemoradiotherapy.
@ast
Id1 and Id3 co-expression corr ...... definitive chemoradiotherapy.
@en
prefLabel
Id1 and Id3 co-expression corr ...... definitive chemoradiotherapy.
@ast
Id1 and Id3 co-expression corr ...... definitive chemoradiotherapy.
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P478
P50
P577
P5875
P6179
P698
P921
P932
P356
P1433
P1476
Id1 and Id3 co-expression corr ...... h definitive chemoradiotherapy
@en
P2093
P2860
P2888
P304
P31
P356
P478
P50
P577
P5875
P6179
P698
P921
P932